The EurA1c trial, organized yearly, investigates the performance of HbA1c assays across countries and manufacturers. EQA organisers of different countries use the same two samples either in their regular EQA program or stand-alone. Results of all countries are evaluated and presented in terms of performances per country and per manufacturer. The trial has Eurocentric roots but, in the meantime, also non-European countries are participating.
Since 2016, Sebia instruments have demonstrated excellent performances for both whole blood and lyophilised samples.
Furthermore, the number of Sebia instruments participating in this important EQA has tremendously increased over these past years, demonstrating the adoption of this technique by the laboratories, as the technique of choice for an accurate and robust HbA1c measurement.
CAPILLARYS 3 TERA MC
Die Leistung von bis zu 36 Kapillaren in einer automatisierten hochvolumigen Gerätekonfiguration.
CAPILLARYS 3 TERA TLA
Verbinden Sie unser flexibles Elektrophorese-Instrument mit Ihrer Laborstraße.
MINICAP FLEX-PIERCING
Kompakte und erschwingliche Automatisierung der Kapillarelektrophorese.
CAPILLARYS 3 TERA TLA
Verbinden Sie unser flexibles Elektrophorese-Instrument mit Ihrer Laborstraße.
CAPILLARYS 3 TERA TLA
Verbinden Sie unser flexibles Elektrophorese-Instrument mit Ihrer Laborstraße.
CAPILLARYS 3 TERA TLA
Verbinden Sie unser flexibles Elektrophorese-Instrument mit Ihrer Laborstraße.
CAPILLARYS 3 TERA TLA
Verbinden Sie unser flexibles Elektrophorese-Instrument mit Ihrer Laborstraße.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.